Market news
Stocks and crypto headlines from Alpaca. Stored for 7 days. Total: 9561.
-
Helyx Industries Announces Expiration of 2021-2026 WarrantsHelyx Industries confirmed the conclusion of the final exercise period for its 2021-2026 warrants, resulting in the expiration of all remaining outstanding warrants.
-
Mostostal Warszawa Signs Contract for Poznań University of Technology Building ExpansionMostostal Warszawa S.A. has entered into a contract for the design and expansion of a building for the Poznań University of Technology.
-
aap Implantate AG Announces Capital Increase and Debt-to-Equity Swapaap Implantate AG has resolved to conduct a rights issue to raise capital and plans a debt-to-equity conversion to strengthen its liquidity and balance sheet.
-
4C Group AB (publ) Publishes Q3 2026 Interim Report4C Group AB (publ) released its interim report for the third quarter of 2026 on November 3, 2026.
-
Valbiotis Delivers First Order to Chinese Joint VentureValbiotis has delivered the first order of its ValbiotisPRO range to its Chinese joint venture, marking a step toward a commercial launch in China by the end of 2026.
-
Hoftex Group AG Announces Results of ERWO Holding's Voluntary Tender OfferHoftex Group AG reported the outcome of a voluntary public tender offer by ERWO Holding Aktiengesellschaft, which resulted in ERWO increasing its stake in the company to 86.41%.
-
Fleury Michon Share Buyback DisclosureFleury Michon has published its weekly declaration of share repurchase transactions conducted between October 26 and October 30, 2026.
-
Montega AG Updates Research on FORTEC Elektronik AGMontega AG has reaffirmed its 'Buy' rating for FORTEC Elektronik AG and increased its price target to 16.00 EUR.
-
Qualisys Launches Prisma Pose Markerless Motion Capture EngineQualisys has introduced Prisma Pose, a new markerless motion capture engine integrated into its Qualisys Track Manager (QTM) software.
-
GiG Software CFO DepartsGiG Software P.L.C. has announced the departure of its Chief Financial Officer.
-
Moberg Pharma Granted U.S. Patent for Improved Dosing of MOB-015Moberg Pharma announced that the United States Patent and Trademark Office (USPTO) has granted a patent for an improved dosing regimen for its topical nail fungus treatment, MOB-015.
-
Enapter AG Announces Cash Capital Increase with Subscription RightsEnapter AG has resolved to conduct a cash capital increase with subscription rights for existing shareholders, supported by a backstop commitment of up to EUR 12 million from a strategic investor.
-
Novacyt Announces Monthly Liquidity Agreement UpdateNovacyt provided its monthly update regarding share transactions conducted under its liquidity agreement with Invest Securities SA for October 2026.
-
Webstep ASA CEO Anne Kristine Lund to Step DownWebstep ASA has announced that Anne Kristine Lund will be stepping down from her position as Chief Executive Officer.
-
Freemelt Proposes SEK 151.8 Million Rights IssueFreemelt Holding AB (publ) has proposed a rights issue to raise approximately SEK 151.8 million to support its long-term funding and path to positive cash flow.
-
Freemelt Reports Preliminary Q3 2026 Financial ResultsFreemelt Holding AB (publ) announced preliminary third-quarter 2026 financial results, highlighting a significant increase in order intake driven by a major customer contract.
-
Aixia AB Secures SEK 35 Million Order for AI InfrastructureAixia AB, a subsidiary of White Pearl Technology Group AB, has won a new order from a major existing customer to provide advanced network infrastructure for next-generation AI factories.
-
Amadeus Fire AG Reports Nine-Month 2026 Results and Confirms Full-Year OutlookAmadeus Fire AG reported a 5.7% decline in nine-month 2026 revenue to €261.5 million while confirming its full-year revenue and operating EBITA guidance.
-
WeGrow AG Reports Insider Share Sale by Management Board MemberWeGrow AG disclosed that Peter Dießenbacher, a member of the management board, sold company shares on October 29, 2026.
-
Cereno Scientific to Host Investigator Meeting for Phase IIb EPIMODE TrialCereno Scientific announced it will host an investigator meeting in Boston on December 2, 2026, for its global Phase IIb EPIMODE trial of CS1.